A Marc Lichtenfeld Exclusive Event on Thursday, June 27, at 2 p.m. ET...

Why Nvidia Is Going All-In On This $10 TechBio Stock

And why you should get in before July 1, ahead of the next cash wave

WHEN: THURSDAY, JUNE 27, 2024, at 2:00 P.M. ET

Back to Event Updates

Biotech’s BIG Problem (And the best solution)

Marc here…

Are you familiar with Moore’s law?

It states that the number of transistors on a microchip doubles about every two years. This leads to increased computing power and lower costs, driving rapid advancements in technology.

You can look back over 50 years and see this pattern play out…

But Moore’s law has an evil twin…

Eroom’s law (“Moore” spelled backward).

And it says that the cost of developing new drugs roughly doubles every nine years despite all of these advancements in technology.

So the more money we spend, the fewer drugs we find!

As it stands now, 90% of drugs fail clinical trials.

Discovery and development can take up to 16 years. AND it costs as much as $2 billion to bring a drug to market.

But, folks, at long last… after DECADES of this frustrating law holding true… it looks like we’re finally turning a corner.

The hero?

Artificial intelligence.

AI can analyze large datasets to identify potential drug targets.

Generative AI models can design novel drug-like molecules from scratch.

It can optimize clinical trials.

And a whole lot more.

The end result? Not only faster, cheaper and more effective drugs… but an absolute windfall for smart investors positioned ahead of this revolution.

When all is said and done, experts predict that by 2040, generative AI could result in $1 trillion value for healthcare.

European fund manager, Hans Peter Portner, expects biotech stocks to get swooped into this next phase of AI euphoria after missing out on the first leg. (Which means the upside could really be INSANE.)

And mark my words, THIS is where AI will have the biggest economic impact… and where early investors can make a killing.

But how? Where?

That’s what you’ll discover on June 27 at 2 p.m. ET at my exclusive event. I’m so glad you’ll be joining me.

But for fun, I’ll give you a brief hint…

As I mentioned before, it’s trading for less than $10.

It’s a fairly young company.

And if the CEO is right, its technology will get drugs into trials after just one or two years… and for just $10-$20 million!

Now THAT would be truly game-changing.

On June 27, I’ll tell you the unique way I plan on playing this for potential maximum gains.

If you click this calendar icon below, you can set yourself a reminder.

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Better yet, I strongly urge you to join our FREE VIP text messaging service. It’s a great resource that keeps you up to date with everything leading up to the big event.

Not only will we text you on June 27 so you don’t miss it, but we’ll also text you any future communications just like what you’re reading from me now.

Just make sure you don’t miss out. Remember, this small company is about to make an announcement that could be truly groundbreaking.

Tomorrow I’ll be back with another update explaining more about how lucrative it can be trading stock catalysts… and how I came to become an expert on the subject.

Talk to you again tomorrow,

Marc

P.S. In case you missed my first email explaining detailing Nvidia’s “Midas Touch” and how to make that work for YOU… go here to review all of our existing messages now.

www.techbiorevolution.com

We’re posting all the articles there so you never miss one.

I look forward to seeing you on June 27!